PALI — PALISADE BIO INC

Ownership history in TWO SIGMA SECURITIES, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which TWO SIGMA SECURITIES, LLC reported a position in PALISADE BIO INC (PALI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 29,406 +13,437 +84.1% 0.00% $25K $0.86
2025 Q2 ADDED 15,969 +1,816 +12.8% 0.00% $11K $0.68
2025 Q1 INITIATED 14,153 — — 0.00% $10K $0.68
% of Fund (quarterly)    PALI price (monthly, adj. close)

Other funds also holding PALI

As of 2025 Q4 — sorted by position size

B Group, Inc. 7.81% Octagon Capital Advisors LP 3Y 2.73% Commodore Capital LP 3Y 1.79% STEMPOINT CAPITAL LP 1.69% Exome Asset Management LLC 0.85% HighVista Strategies LLC 3Y 7Y 0.79% Artia Global Partners LP 3Y 0.66% Eversept Partners, LP 3Y 7Y 0.64% Seven Fleet Capital Management LP 0.59% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.5%
← Back to TWO SIGMA SECURITIES, LLC Holdings